Back to today’s briefing

Story perspectives

Eli Lilly Cuts Zepbound Prices to Enhance Accessibility

2/28/2025

42 9

Summary

Story summary

Eli Lilly is taking a bold step to make its Zepbound diabetes and obesity treatment more accessible, slashing prices for new doses. The 2.5 mg will now cost $349, and the 5 mg will be available for $499. This strategic move comes as competition heats up, ensuring more patients can afford this vital medication.

1 of 1

Story summary

Eli Lilly is taking a bold step to make its Zepbound diabetes and obesity treatment more accessible, slashing prices for new doses. The 2.5 mg will now cost $349, and the 5 mg will be available for $499. This strategic move comes as competition heats up, ensuring more patients can afford this vital medication.